** Shares of Hims & Hers HIMS.N rise 43% to $40.73 premarket
** Novo Nordisk NOVOb.CO has partnered with the telehealth firm to sell its popular weight loss drug through a bundled offering on HIMS platform
** Starting this week, customers will get access to the offerings of all dose strengths of Wegovy and a membership at a price starting at $599 per month - HIMS
** HIMS says it will continue to offer personalized compounded versions of semaglutide, the active ingredient in Novo's Wegovy
** Earlier this month, HIMS said it plans to sell Eli Lilly's LLY.N Zepbound on its platform
** Up to last close, HIMS up 17.8% YTD
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。